Lloyd Klickstein's most recent trade in Adicet Bio Inc was a trade of 26,400 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adicet Bio Inc | Lloyd Klickstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 26,400 | 26,400 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Lloyd Klickstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 5,900 | 108,566 | - | 0 | Common Stock | |
| Adicet Bio Inc | Lloyd Klickstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 70,200 | 70,200 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Lloyd Klickstein | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 41,100 | 41,100 | - | - | Stock Option (Right to Buy) | |
| Adicet Bio Inc | Lloyd Klickstein | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 16,888 | 16,888 | - | 0 | Common Stock | |
| Adicet Bio Inc | Lloyd Klickstein | Chief Innovation Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Jan 2021 | 4,957 | 11,931 | - | 0 | Common Stock | |
| Adicet Bio Inc | Lloyd Klickstein | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2021 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) |